Pediatric Antidepressant Safety: “Jury Is Still Out,” FDA Tells Congress

Discussion of regulatory status of antidepressant indications is almost an afterthought during Sept. 9 House hearing. FDA’s Woodcock, however, stresses that agency is not ready to rule out a role for antidepressants in children.